Role of connective tissue growth factor in renal tubular epithelial-myofibroblast transdifferentiation and extracellular matrix accumulation in vitro

Life Sciences

Volumn 75, Issue 3, 2004, Pages 367-379

  Zhang, Chun ^a   Meng, Xianfang ^b   Zhu, Zhonghua ^a   Yang, Xiao ^a   Deng, Anguo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

smooth muscle actin; Antisense oligodeoxynucleotide; Connective tissue growth factor; Fibronectin; Plasminogen activator inhibitor 1; Renal tubular epithelial cells

Indexed keywords

ALPHA ACTIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INCUBATION TIME; KIDNEY FIBROSIS; KIDNEY TUBULE EPITHELIUM; MYOFIBROBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ACTINS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBRONECTINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TUBULES; MITOGENS; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 2342512104     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.02.005     Document Type: Article

References (29)

1. Badid C., Vincent M., Fouque D., Laville M., Desmouliere A. Myofibroblast: a prognostic marker and target cell in progressive renal disease. Renal Failure. 23:2001;543-549
2. Basile D.P. The transforming growth factor beta system in kidney disease and repair: recent progress and future directions. Current Opinion in Nephrology and Hypertension. 8:1999;21-30
3. Becker G.J., Hewitson T.D. The role of tubulointerstitial injury in chronic renal failure. Current Opinion on Nephrology and Hypertension. 9:2000;133-138
4. Border W.A., Yamamoto T., Noble N.A. Tranforming growth factor beta in diabetic nephropathy. Diabetes Metabolism Review. 12:1996;309-339
5. Border W.A., Noble N.A. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney International. 1:1997;1388-1396
6. Bradham D.M., Igarashi A., Potter R.I., Grotendorst G.R. Connective tissue growth factor: a cystein-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. Journal of Cell Biology. 114:1991;1285-1294
7. Duncan M.R., Frazier K.S., Abramson S., Williams S., Klapper H., Huang X., Grotendorst G.R. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. FASEB Journal. 13:1999;1774-1786
8. Eddy A.A. Molecular insights into renal interstitial fibrosis. Journal of American Society of Nephrology. 7:1996;2495-2508
9. Eddy A.A. Molecular basis of renal fibrosis. Pediatric Nephrology. 15:2000;290-302
10. Eddy A.A. Plasminogen activator inhibitor-1 and the kidney. American Journal of Physiology Renal Physiology. 283:2002;F209-F220
11. Fan J.M., Ng Y.Y., Hill P.A., Nikolic-Paterson D.J., Mu W., Atkins R.C., Lan H.Y. Transforming growth factor-beta regulates tubular epithelial- myofibroblast transdifferentiation in vitro. Kidney International. 56:1999;1455-1467
12. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G.R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. Journal of Investigation on Dermatology. 107:1996;404-411
13. Goldschmeding R., Aten J., Ito Y., Blom I., Rabelink T., Weening J.J. Connective tissue growth factor: just another factor in renal fibrosis? Nephrology Dialysis and Transplantation. 15:2000;296-299
14. Gore-Hyer E., Shegogue D., Markiewicz M., Lo S., Hazen-Martin D., Greene E.L., Grotendorst G., Trojanowska M. TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. American Journal of Physiology Renal Physiology. 283:2002;F707-F716
15. Grotendorst G.R., Okochi H., Hagash N. A novel transforming growth factor β response element controls the expression of connective tissue growth factor gene. Cell Growth and Differentiation. 7:1996;469-480
16. Han D.C., Hoffman B.B., Hong S.W., Guo J., Ziyadeh F.N. Therapy with antisense TGF-beta 1 oligodeoxynucleotides reduces kidney weight and matrix mRNA in diabetic mice. American Journal of Physiology Renal Physiology. 278:2000;F628-F634
17. Heidland A., Sebekova K., Paczek L., Teschner M., Dammrich J., Gaciong Z. Renal fibrosis: Role of impaired proteolysis and potential therapeutic strategies. Kidney International Supplement. 62:1997;s32-s35
18. Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Molecular Biology of the Cell. 4:1993;637-645
19. Inoue T., Okada H., Kobayashi T., Watanabe Y., Kanno Y., Kopp J.B., Nishida T., Takigawa M., Ueno M., Nakamura T., Suzuki H. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB Journal. 17:2003;268-270
20. Inoue T., Okada H., Kobayashi T., Watanabe Y., Kikuta T., Kanno Y., Takigawa M., Suzuki H. TGF-beta1 and HGF coordinately facilitate collagen turnover in subepithelial mesenchyme. Biochemical and Biophysical Research Communications. 297:2002;255-260
21. Ito Y., Aten J., Bende R.J., Oemar B.S., Rabelink T.J., Weening J.J., Goldschmeding R. Expression of connective tissue growth factor in human renal fibrosis. Kidney International. 53:1998;853-861
22. Nahas A.M., Muchaneta-Kubara E.C., Essawy M., Soylemezoglu O. Renal fibrosis: insights into pathogenesis and treatment. International Journal of Biochemistry and Cell Biology. 29:1997;55-62
23. Nath K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. American Journal of Kidney Diseases. 20:1992;1-17
24. Roberts A.B., McCune B.K., Sporn M.B. TGF-β: regulation of extracellular matrix. Kidney International. 41:1992;557-559
25. Strutz F., Muller G.A., Neilson E.G. Transdifferentiation: a new angle on renal fibrosis. Experimental Nephrology. 4:1996;267-270
26. Wang S., Denichilo M., Brubaker C., Hirschberg R. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney International. 60:2001;96-105
27. Wang S., Hirschberg R. BMP7 antagnized TGF-β-dependent fibrogenesis in mesangial cells. American Journal of Physiology Renal Physiology. 284:2003;F1006-F1013
28. Yokoi H., Mukoyama M., Sugawara A., Mori K., Nagae T., Makino H., Suganami T., Yahata K., Fujinaga Y., Tanaka I., Nakao K. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. American Journal of Physiology Renal Physiology. 282:2002;F933-F942
29. Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-De La Cruz M.C., Hong S.W., Isono M., Chen S., McGowan T.A., Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proceedings of the National Academy of Sciences USA. vol. 97:2000;8015-8020